Identification of the gene notch3 as a novel biomarker for human metastatic melanoma
AssigneeThe Johns Hopkins University
InventorsRhoda Myra Alani, Jason David Howard
Life of this patent
Estimating the term…
Abstract
The present invention provides evidence that Notch3 gene upregulation is associated with invasive metastatic melanoma. Assays for quantifying Notch3 expression in biological samples and methods of use for diagnosis, and assaying progression and treatment outcome using these assays are also provided. Methods of screening for compounds which inhibit Notch3 expression are also provided.
Claims17
A method for detecting or diagnosing melanoma in a subject comprising:
- (a) obtaining a biological sample from the subject;
- (b) detecting the presence of i) cells expressing Notch3, ii) soluble Notch3, or iii) a soluble fragment of Notch3 in the sample;
- and
- (c) correlating the expression of Notch3 with the presence of melanoma, thereby detecting or diagnosing melanoma in a subject.
A method of predicting recurrence of melanoma in a subject comprising:
- (a) obtaining a biological sample from the subject;
- (b) detecting the presence of i) cells expressing Notch3, ii) soluble Notch3, or iii) a soluble fragment of Notch3 in the sample;
- and
- (c) correlating the expression of Notch3 with the presence of melanoma, thereby predicting the recurrence of melanoma in a subject.
A method of identifying a subject at risk of developing melanoma comprising:
- (a) obtaining a biological sample from the subject;
- (b) detecting the presence of i) cells expressing Notch3, ii) soluble Notch3, or iii) a soluble fragment of Notch3 in the sample;
- and
- (c) correlating the expression of Notch3 with the presence of melanoma, thereby identifying a subject at risk of developing melanoma.
A method for screening one or more Notch3 activity inhibitor candidates comprising:
- 1) constructing a transformant by transfecting a host cell with a plasmid comprising a polynucleotide encoding Notch3;
- 2) treating the transformant with a control substance, and treating the transformant with one or more Notch3 activity inhibitor candidates (experimental group);
- 3) measuring Notch3 activities in the experimental group and in the control group of step 2);
- and
- 4) selecting Notch3 activity inhibitor candidates that demonstrate an inhibitory effect when compared with the control group.
Dependencies are inferred from the claim text.